GlassScriptPhysician profile
Carlos I Alarcon
NPI 1568481539
$7,242.43
in general payments reported to CMS, 2019-2025
45 companies · $784 in 2025
The $784 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $274 · 2021: $454 · 2022: $665 · 2023: $778 · 2024: $3,660 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,099 · Food and Beverage: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,099.00 |
| Food and Beverage | $2,121.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,469.16 | 2019-2024 | |
| Abbvie INC. | $409.96 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $323.62 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $228.73 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $184.94 | 2022-2024 | |
| Organon LLC | $183.75 | 2022-2025 | Nexplanon, Jada System, Nuvaring |
| Hologic Sales and Service, LLC | $175.07 | 2023-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Fetal Fibronectin Enzyme Immunoassay |
| Sumitomo Pharma America, INC. | $173.86 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $155.94 | 2024-2025 | |
| Exeltis, USA INC. | $133.59 | 2019-2025 | Slynd |
| Boston Scientific Corporation | $131.60 | 2019 | |
| Myovant Sciences INC. | $130.68 | 2022 | |
| Evofem Biosciences, INC. | $123.44 | 2021-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $116.15 | 2019-2025 | |
| Biogen, INC. | $115.81 | 2025 | Zurzuvae |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $110.16 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Dysis Medical, INC. | $108.51 | 2023 | Dysis V3 Digital Coploscope, Dysis Ultra 2.0, Dysis View |
| Smith+Nephew, INC. | $74.92 | 2019-2024 | Acticoat 4" X 4", Pico 7, Pico 14 |
| Cumberland Pharmaceuticals, INC. | $67.65 | 2021-2023 | Caldolor |
| Daiichi Sankyo INC. | $67.49 | 2019-2021 | |
| Agile Therapeutics, INC. | $67.18 | 2022-2024 | Twirla |
| Optumhealth Care Solutions, LLC | $66.04 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Therapeuticsmd, INC. | $55.74 | 2019-2020 | |
| Davol INC. | $50.33 | 2024 | Arista Ah Flexitip |
| Avion Pharmaceuticals | $46.73 | 2019-2022 | |
| Duchesnay USA Incorporated | $45.84 | 2019 | |
| Merck Sharp & Dohme LLC | $43.90 | 2019-2024 | Gardasil, Gardasil 9 |
| Alydia Health | $37.90 | 2021 | |
| Medtronic, INC. | $36.89 | 2025 | |
| Amag Pharmaceuticals, INC. | $30.60 | 2019 | |
| Meditrina | $29.54 | 2022-2024 | |
| Gynesonics, INC. | $28.86 | 2022 | |
| Millicent US INC | $27.72 | 2019-2020 | |
| Lupin INC. | $27.01 | 2019 | |
| Heron Therapeutics, INC. | $20.19 | 2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $18.25 | 2023 | Exparel |
| Olympus America INC. | $16.81 | 2022 | |
| Exact Sciences Corporation | $15.25 | 2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $15.14 | 2020 | |
| Allergan, INC. | $14.33 | 2020 | |
| Kci USA, INC. | $14.05 | 2023 | Prevena |
| Aspira Women'S Health INC | $13.57 | 2021 | |
| Mission Pharmacal Company | $13.54 | 2019 | |
| Minerva Surgical, INC | $13.43 | 2022 | |
| Channel Medsystems, INC. | $8.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Alarcon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.